Model
Edge
Alnylam Pharmaceuticals, Inc.
0001226287
Filing type
4
Filing date
Mar 8, 2023
Updated
Mar 9, 2023 ยท 9:12 AM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership